Open AccessPropolis and its bioactive chemical constituents offer a novel and sustainable treatment option for kinetoplastid infections
Author(s) -
Godwin U. Ebiloma,
John O. Igoli,
David G. Watson,
Harry P. de Koning
Publication year - 2021
Publication title -
proceedings of 7th international electronic conference on medicinal chemistry
Language(s) - English
Resource type - Conference proceedings
DOI - 10.3390/ecmc2021-11499
Subject(s) - kinetoplast , propolis , trypanosoma , miltefosine , leishmaniasis , biology , leishmania , trypanosoma brucei , trypanosoma evansi , kinetoplastida , trypanosoma cruzi , protozoa , microbiology and biotechnology , virology , trypanosomiasis , immunology , parasite hosting , biochemistry , malaria , botany , dna , protozoal disease , visceral leishmaniasis , world wide web , computer science , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom